3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
22
Phase 1
11
Phase 1/2
7
Phase 3
4
Phase 2/3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Conditions
Carcinoma, Non-Small-Cell Lung
13
Lung Neoplasms
5
Mesothelioma
4
Neoplasms
2
NSCLC
2
Recurrence
1
Nonsquamous Non-small Cell Lung Cancer
1
Non-squamous Non-small Cell Lung Cancer
1
Mesothelioma, Malignant
1
Adenocarcinoma of Lung
1
Interventions
Pemetrexed
1
Cisplatin
1
Carboplatin
1
ADI PEG20
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2/3
×
Mesothelioma, Malignant
×
Pemetrexed
×
Clear all
NCT02709512
2023-10-04
ATOMIC
Polaris Group
Phase 2/3
Completed
249 enrolled
17 charts